If its not for you, just let us know within 12 months, and youll get your money back
In the published Phase I dose-escalation study in healthy adults, CJC-1295 with DAC showed good tolerability, with injection-site reactions reported as the most common adverse effect
It was even actively investigated for medical use, but because of adverse effects especially affecting the eyes, most clinical trials were halted in 1965 by the United States Food and Drug Administration (FDA)
Under federal law (Sections 503A and 503B of the FD&C Act), a drug can only be compounded if it is a component of an FDA-approved medication or appears on an official "shortage list." No Approved Base: Since no FDA-approved version of Retatrutide exists yet, there is no legal "recipe" or standard for compounders to follow
Semax (ACTH 4-10 analogue) upregulates acetylcholine release and increases brain-derived neurotrophic factor (BDNF), producing enhanced focus and working memory through cholinergic and dopaminergic pathways
More recent research has tested doses up to 7.2 mg and even 16 mg weekly, with greater weight loss but also increased gastrointestinal side effects
